| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |